title: [Spasticity. Physical therapy, preventive measures and treatment].
abstract: Spasticity is one of the most common motor and tonus disorders during the initial phase with traumatic brain injured patients. The evaluation of spasticity is mainly clinical but it is very important to prevent complications such as limitation of range of motion, pain, decubitus ulcers. The therapeutic options consist in classical indications such as baclofen, dantrolene, tizanidine, benzodiazepine, associated with physiotherapy. Other additive therapeutic options could be discussed: use of toxin botulinum in focal spasticity and intrathecal baclofen infusion in case of severe spasticity (often associated with dysautonomic disorders.).
authors.affiliation: Centre de l'Arche, 72650 Saint-Saturnin, France. arche.gay@antivirus.oleane.com
authors.forename: S
authors.initials: S
authors.lastname: Gay
authors.forename: G
authors.initials: G
authors.lastname: Egon
mesh_terms: D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D001930:Brain Injuries / Q000150:complications*; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D026741:Physical Therapy Modalities
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins